BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19889954)

  • 1. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells.
    Dong G; Luo J; Kumar V; Dong Z
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F293-300. PubMed ID: 19889954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of extracellular matrix renal tubulo-interstitial nephritis antigen (TINag) in cell survival utilizing integrin (alpha)vbeta3/focal adhesion kinase (FAK)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B-serine/threonine kinase (AKT) signaling pathway.
    Xie P; Kondeti VK; Lin S; Haruna Y; Raparia K; Kanwar YS
    J Biol Chem; 2011 Sep; 286(39):34131-46. PubMed ID: 21795690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KiSS-1 Modulation by Epigenetic Agents Improves the Cisplatin Sensitivity of Lung Cancer Cells.
    Beretta GL; Alampi D; Corno C; Carenini N; Corna E; Perego P
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers.
    Zhou Y; Luo Q; Zeng F; Liu X; Han J; Gu L; Tian X; Zhang Y; Zhao Y; Wang F
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion from basal histone H4 hypoacetylation at the replication fork increases DNA damage in FANCA deficient cells.
    Teresa BG; Ayala-Zambrano C; González-Suárez M; Molina B; Torres L; Rodríguez A; Frías S
    PLoS One; 2024; 19(5):e0298032. PubMed ID: 38820384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together.
    Wawruszak A; Luszczki J; Halasa M; Okon E; Landor S; Sahlgren C; Rivero-Muller A; Stepulak A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Modifications in Acute Kidney Injury.
    Wang J; Shen F; Liu F; Zhuang S
    Kidney Dis (Basel); 2022 Dec; 8(6):466-477. PubMed ID: 36590679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD
    Iskander A; Yan LJ
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected Enhancement of Cytotoxicity of Cisplatin in a Rat Kidney Proximal Tubular Cell Line Overexpressing Mitochondrial Glutathione Transport Activity.
    Lash LH
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy.
    Hu X; Ma Z; Wen L; Li S; Dong Z
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update.
    Loren P; Saavedra N; Saavedra K; Zambrano T; Moriel P; Salazar LA
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34063951
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yeh SH; Lin MH; Leo Garcia Flores II; Mukhopadhyay U; Young D; Ogawa K; Jeong JH; Tong W; Gelovani JG; Fukumitsu N
    Mol Imaging; 2021; 2021():6660358. PubMed ID: 33867871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus Polysaccharide Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Damage and Mitochondrial Dysfunction.
    Ma Q; Xu Y; Tang L; Yang X; Chen Z; Wei Y; Shao X; Shao X; Xin Z; Cai B; Wang Q; Mou S
    Biomed Res Int; 2020; 2020():2851349. PubMed ID: 31998784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics study of fasudil on cisplatin-induced kidney injury.
    Xia D; Lai X; Wu K; Zhou P; Li L; Guo Z; Xu S
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31670380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Found in Translation: Reasons for Optimism in the Pursuit to Prevent Chronic Kidney Disease After Acute Kidney Injury.
    Silver SA; Gerarduzzi C
    Can J Kidney Health Dis; 2019; 6():2054358119868740. PubMed ID: 31452903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Activation of Sirt1 Ameliorates Cisplatin-Induced Acute Kidney Injury by Suppressing Apoptosis, Oxidative Stress, and Inflammation in Mice.
    Kim JY; Jo J; Kim K; An HJ; Gwon MG; Gu H; Kim HJ; Yang AY; Kim SW; Jeon EJ; Park JH; Leem J; Park KK
    Antioxidants (Basel); 2019 Aug; 8(8):. PubMed ID: 31431003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications.
    Guo C; Dong G; Liang X; Dong Z
    Nat Rev Nephrol; 2019 Apr; 15(4):220-239. PubMed ID: 30651611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling epigenetic modifications in renal development and disease with organoids and genome editing.
    Hurtado Del Pozo C; Garreta E; Izpisúa Belmonte JC; Montserrat N
    Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30459215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.
    Sun L; Liu J; Yuan Y; Zhang X; Dong Z
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F469-F478. PubMed ID: 29767555
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Fukumitsu N; Yeh SH; Flores Ii LG; Mukhopadhyay U; Young D; Ogawa K; Jeong HJ; Tong W; Gelovani JG
    Contrast Media Mol Imaging; 2018; 2018():3612027. PubMed ID: 29755299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.